Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Article summary

Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on October 20, 2026 under the Company's 2026 Employment Inducement Incentive Award Plan (the "2026 Inducement Plan") as a material inducement to...